Who Paid My Doc
M23-477 ABBV-787 Ph 1 3L AML Study
ClinicalTrials.gov NCT06068868
Research payments
$7,980
Through program year 2024, $7,980 in research payments was reported against M23-477 ABBV-787 Ph 1 3L AML Study, across 13 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT06068868
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $7,980 | 13 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Amer Zeidan New Haven, CT Named on 1 payment
- Andrew Sochacki Grand Rapids, MI Named on 1 payment
- Anthony Stein Duarte, CA Named on 1 payment
- Catherine Lai Philadelphia, PA Named on 1 payment
- Yasmin Abaza Chicago, IL Named on 1 payment
- Gail Roboz New York, NY Named on 1 payment
- Brian Jonas Sacramento, CA Named on 1 payment
- Maria Baer Baltimore, MD Named on 1 payment
- Mary-Elizabeth Percival Seattle, WA Named on 1 payment
- Naval Daver Houston, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.